Results 201 to 210 of about 2,641,102 (341)

Patient selection in a randomized lung cancer trial [PDF]

, 1986
Rolf Holle, P. Drings, S. Hirschberger, K. Havemann   +3 more
openalex   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Surgical Management of Desmoid Tumors-Patient Selection, Timing, and Approach. [PDF]

Curr Oncol
Lazcano CS, Gronchi A.
europepmc   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation. [PDF]

JCO Oncol Pract
Strouse C, Juckett M, Logan BR, Estrada-Merly N, Peterson A, Preussler JM, Truong TH, Troy JD, Khera N, Wood WA, Rangarajan HG, Akard LP, Bhatt NS, Sharma A, Rizzo JD, Saber W.   +15 more
europepmc   +1 more source

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

d-Dimer With the Aortic Dissection Detection Risk Score May Improve Patient Selection for Acute Aortic Syndrome Diagnostic Imaging. [PDF]

Emerg Med Australas
Bhat S, Bhat S, Schreve F, Bergin CJ, Jones PG, Waqanivavalagi SWFR.   +5 more
europepmc   +1 more source

Postoperative ischemic events in patients undergoing carotid artery stenting using algorithmic selection for embolic protection

, 2019
Yasuhiro Kawabata, Norio Nakajima, Hidenori Miyake, Shunichi Fukuda, Tetsuya Tsukahara   +4 more
openalex   +2 more sources

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

Molecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto, Louise Raunkilde, Jan Lindebjerg, Mads Malik Aagaard, Christina Therkildsen, Jakob Kleif, Lars Henrik Jensen, Torben Frøstrup Hansen, Rikke Fredslund Andersen   +8 more
wiley   +1 more source

Practical Considerations for Dose Selection in Pediatric Patients to Ensure Target Exposure Requirements [PDF]

, 2014
April Barbour, Michael J. Fossler, Jeffrey S. Barrett   +2 more
openalex   +1 more source